HBCN — Healthbeacon Share Price
Last trade - 00:00Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -40.4% | ||
| Return on Equity | -66.6% | ||
| Operating Margin | -329.63% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 1.35 | 1.58 | 1.21 | 2.21 | 2.25 | 16 | 33.68 | 13.7% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
HealthBeacon plc is an Ireland-based digital therapeutics company. The Company develops products for managing injectable medications for patients in the home. The Company operates through two segments: Direct-to-Consumer (DTC) and Patient Support Programmes (PSP). Its Injection Care Management System tracks adherence and persistence with medication schedules through the provision of medication management reminders, safe and sustainable sharps disposal devices, educational tools, and artificial intelligence-driven data analytics. It accesses the end patient through three distinct distribution channels, such as PSP, DTC, and Reimbursed Digital Therapeutics. It delivers technology-enabled waste management solutions. It also develops smart tools for managing medications. The Company operates in over 17 countries primarily across Europe, North America, and the United Kingdom.
Directors
- Last Annual
- December 31st, 2022
- Last Interim
- December 31st, 2021
- Incorporated
- July 25th, 2013
- Public Since
- December 15th, 2021
- No. of Employees
- 63
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Irish Stock Exchange
- Shares in Issue
- 16,889,626
- Address
- Unit 20 Naas Road Business Park, DUBLIN, D12 WD85
- Web
- https://healthbeacon.com/
- Phone
- +353 14508480
- Auditors
- Grant Thornton
Latest News for HBCN
Upcoming Events for HBCN
FAQ
As of Today at 18:10 UTC, shares in Healthbeacon are trading at €0.07. This share price information is delayed by 15 minutes.
Shares in Healthbeacon last closed at €0.07 and the price had moved by -96.73% over the past 365 days. In terms of relative price strength the Healthbeacon share price has underperformed the FTSE Global All Cap Index by -96.59% over the past year.
The overall consensus recommendation for Healthbeacon is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Healthbeacon does not currently pay a dividend.
Healthbeacon does not currently pay a dividend.
Healthbeacon does not currently pay a dividend.
To buy shares in Healthbeacon you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €0.07, shares in Healthbeacon had a market capitalisation of .
Here are the trading details for Healthbeacon:
- Country of listing: Ireland
- Exchange: ISE
- Ticker Symbol: HBCN
Based on an overall assessment of its quality, value and momentum Healthbeacon is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Healthbeacon. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -92.29%.
As of the last closing price of €0.07, shares in Healthbeacon were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Healthbeacon PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at €0.07.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Healthbeacon's directors